Wearable magnetic field therapy device for brain cancer
Official title: Novel wearable rotating magnetic field therapy device targeting treatment of brain cancers
Funded at Biotex, INC. · NIH-11417972 · Data updated 2026-11-12
A small, non-invasive wearable device uses rotating magnetic fields to target brain cancers in adults.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biotex, INC. NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 18, 2025 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $936,698 |
| NIH project number | 5R44CA302219-02 |
| Project ID | NIH-11417972 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with brain cancers, particularly glioblastoma, who may be eligible for non-invasive device-based therapy trials.
✕Less likely to help
Patients with brain cancers who require immediate standard therapies or who may not be eligible for device-based approaches.
What this research studies
This project aims to move a new wearable device, the Oncomagnetic Device (OMTx), from development toward clinical use for brain tumors like glioblastoma. It focuses on fast translation and commercialization while keeping treatment non-invasive and potentially less toxic than standard therapies. Researchers will develop the device, validate its safety and feasibility, and plan steps toward early clinical testing in patients with brain cancers. The goal is to offer a new option that could improve quality of life and outcomes for people facing brain tumors.
Why it matters
Potential benefit: If successful, patients with brain cancers could have a non-invasive treatment option that may reduce toxicity and improve quality of life.
How similar studies have gone: Other non-invasive, device-based approaches for brain tumors are being explored, with early promise but not yet standard of care.
Where this research is happening
-
Biotex, INC.
Houston, United States Active
Researchers
- Principal investigator: Gowda, Ashok — Biotex, INC.
- Study coordinator: Gowda, Ashok
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.